Search research articles
Contact Us
Filters
Showing results (11-20 of 16) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 16 results.
EMBO Reports
|
July 18, 2022
Endothelial cell death after ionizing radiation does not impair vascular structure in mouse tumor models
Jakob R Kaeppler, Jianzhou Chen, Mario Buono, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 2, 2019
Hypoxia-induced switch in SNAT2/SLC38A2 regulation generates endocrine resistance in breast cancer
Matteo Morotti, Esther Bridges, Alessandro Valli, et al.
British Journal of Cancer
|
December 11, 2019
Transcriptomic analysis of human primary breast cancer identifies fatty acid oxidation as a target for metformin
Simon R Lord, Jennifer M Collins, Wei-Chen Cheng, et al.
Science Advances
|
June 12, 2026
<i>SHLD2</i> loss is a synthetic vulnerability to Polθ inhibition combined with radiotherapy
Gonzalo Rodriguez-Berriguete, Purusotha Thambiayah, Alessandro Cicconi, et al.
Cell Metabolism
|
September 25, 2018
Integrated Pharmacodynamic Analysis Identifies Two Metabolic Adaption Pathways to Metformin in Breast Cancer
Simon R Lord, Wei-Chen Cheng, Dan Liu, et al.
Ebiomedicine
|
May 7, 2018
Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate Cancer
Lingjian Yang, Darren Roberts, Mandeep Takhar, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 16) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 16 results.
EMBO Reports
|
July 18, 2022
Endothelial cell death after ionizing radiation does not impair vascular structure in mouse tumor models
Jakob R Kaeppler, Jianzhou Chen, Mario Buono, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 2, 2019
Hypoxia-induced switch in SNAT2/SLC38A2 regulation generates endocrine resistance in breast cancer
Matteo Morotti, Esther Bridges, Alessandro Valli, et al.
British Journal of Cancer
|
December 11, 2019
Transcriptomic analysis of human primary breast cancer identifies fatty acid oxidation as a target for metformin
Simon R Lord, Jennifer M Collins, Wei-Chen Cheng, et al.
Science Advances
|
June 12, 2026
<i>SHLD2</i> loss is a synthetic vulnerability to Polθ inhibition combined with radiotherapy
Gonzalo Rodriguez-Berriguete, Purusotha Thambiayah, Alessandro Cicconi, et al.
Cell Metabolism
|
September 25, 2018
Integrated Pharmacodynamic Analysis Identifies Two Metabolic Adaption Pathways to Metformin in Breast Cancer
Simon R Lord, Wei-Chen Cheng, Dan Liu, et al.
Ebiomedicine
|
May 7, 2018
Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate Cancer
Lingjian Yang, Darren Roberts, Mandeep Takhar, et al.
Page
of 2